Intanza

BIOLOGICAL5 trials

Sponsors

Dalhousie University, University of British Columbia, Brenda Coleman, The University of Hong Kong, University of Lausanne Hospitals

Conditions

InfluenzaInfluenza VaccineInfluenza, HumanVaccination Site Reactions (HT)

Phase 2

Imiquimod and Influenza Vaccine for Immunocompromised Patients

CompletedNCT02960815

University of Lausanne HospitalsInfluenza Vaccine

Start: 2016-11-30End: 2017-06-30Updated: 2017-10-10

Phase 4

Study to Compare Self-administered and Nurse-administered Intradermal Influenza Vaccine

CompletedNCT01224613

Dalhousie UniversityInfluenza

Start: 2010-11-30End: 2011-02-28Target: 276Updated: 2011-06-15

Comparison of 4 Influenza Vaccines in Seniors

CompletedNCT01368796

University of British ColumbiaInfluenza Vaccine

Start: 2011-07-31End: 2012-05-31Updated: 2015-04-15

A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine

CompletedNCT01665807

Brenda ColemanInfluenza, Vaccination Site Reactions (HT)

Start: 2012-09-30End: 2012-12-31Updated: 2017-04-19

Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults

The University of Hong KongInfluenza, Human

Start: 2013-10-31End: 2015-06-30Target: 100Updated: 2013-10-22

Related Papers

Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers.

2015-10-319 citations

Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).

2012-08-0763 citations